RSS

CYDY CytoDyn Inc

Mod: mightycydy Asst: HHIGambler,CaptnAmerca
Last Post: 8:03 AM
Followers: 439
Posts Today: 2
Views Today: 69646

CYDY Stock Quote & Tools

$0.2054 ▲ +0.0054 (+2.69%) As of Oct 15, 3:59 PM EDT
Last0.2054
$ Chg0.0054
Open0.2000
High0.2090
Beta1.4964
Year High0.397
Market Cap301.80M
P/B Ratio-2.68
EPS-0.04
Avg Vol (30d)1.57M
Volume3.28M
% Chg+2.69%
Prev Close0.2000
Low0.1971
VWAP0.20198
Year Low0.183
Total Shares1.47B
Shares Out1.47B
Float1.36B
ExchangeOTCQB
Healthcare Biotechnology & Life Sciences
Company Profile Buy Rating Time & Sales News Filings Financials

CYDY Stock Message Board Discussion

3 Pinned Posts
Leronlimab (Pro 140) Cliff Notes What is it? Leronlimab is a humanized monoclo (43) by trding
Leronlimab Regulator List (a work in progress) = upregulation = downregulation a-SMA (21) by ohm20
EIND: Information to Submit to Doctors Leronlimab a humanized monoclonal antibody binds CCR5, (38) by ohm20
  1. CDiddy

    I'm sorry. I'm not comfortable with it. I don't want to be in that position. I share my

    (1)
  2. MD VIROLOGIST

    He doesn't want to convince, just wants to provide accurate information. You can do what you want

  3. sean007

    "shall pertain only to (unregistered anywhere in the world) drugs and vaccines for prevention,

  4. CDiddy

    Yep, I agree completely. The trial is what it is. We either meet the primary endpoint or we

    (2)
  5. LaundryMoney

    I think we are in the same boat. My angle was what the RO would mean to the FDA, which I don't

    (3)
  6. CDiddy

    Man my spell check is having a field day. *I agree

  7. CDiddy

    Is green with the reading of the statute. That EUA is required. Some argue that the partnership

  8. CDiddy

    I'm not comfortable with it. Why does he want to convince me? He can tweet it for all to

    (8)
  9. CDiddy

    Lol. I am no godfather. I just got roped into moderating.

    (1)
  10. CDiddy

    I agree with what you are saying. But I also understand what they are saying, it would be helpful

    (1)
  11. Goosebumps

    The reason we dont need a EUA here first in the USA is because we have a local pharmaceutical

    (1)
  12. CDiddy

    I inadvertently deleted the post about Bruce Patterson wanting to talk to me. I meant to reply to

    (3)
  13. mtruong34

    Thanks for that info Ohm. My original point is that the mortality rate is dependent on the patient

    (1)
  14. Goosebumps

    I was a little abrasive in my reply to you. For that... I apologize... Here is the executive

  15. MD VIROLOGIST

    Yes he wants (BP) to codify some of the posts from (Cdiddy). Delete at will. This has to do with

    (1)
  16. reallypeople?

    Well said . . Expresses my thoughts pretty close.

    (1)
  17. ohm20

    In that particular study 21% of patients in the ICU never progressed to mechanical ventilation. How

  18. LaundryMoney

    I disagree with this statement. Where was the RO test in M/M? Our trial participation was low, plus

    (8)
  19. jeff67

    I posted a CNN Philippines quote a few weeks back from early December that stated the Philippines

    (1)
  20. MD VIROLOGIST

    Never said fatal just important,

  21. MD VIROLOGIST

    Unfortunately because of the crisis lower level patients are admitted and they stay longer because

    (1)
  22. Heads

    Wow, what a peculiar reaction to my post! First of all, did you read the language of the circular?

    (2)
  23. mtruong34

    I think during normal times that would be true, but in a pandemic when the ICU is overflowing they

    (1)
  24. Goosebumps

    I dont buy your attempt at discrediting CYDY or Nader personally. Nader wouldnt say in the

    (1)
  25. ohm20

    I believe the more data the better but not having receptor occupancy is not a fatal flaw in the

    (2)
  26. ohm20

    Your math assumes everyone in the CD12 trial was critical It includes everyone in

    (1)
  27. dfwl28

    CCR5 antagonism is a totally new, totally original theory of medicine." Read More:

  28. mtruong34

    MAV used a mortality rate from Ohm's post which clearly stated 34.7% for intubated patients

    (1)
  29. Heads

    It took two weeks for me to hear back from the Philippines FDA, but this is their response to my

    (3)
  30. 10Blade

    Not a huge musical fan, but owning CYDY makes this song have a special place in my heart.

    (1)
  31. havasu78

    This post by MDV brings to my mind two mind boggling CD12 scenarios. First, MDV offers the

    (3)
  32. Dvb

    I think the following expectation was previously put forth on this or another board and I fully

    (1)
  33. havasu78

    If CD12 obtains EUA, CD12 RO is totally irrelevant. My point is that CD12 RO is useful to drive

  34. HCIT

    Ohm, smurph and everyone. Inflammation is the root of all evil in almost everything. Inflammation

    (3)
  35. calstang

    51% Decrease In Mortality Rate With Leronlimab/.... Why do you say MAV MD is assuming all patients

  36. havasu78

    It certainly could be true that the FDA reviewers of CD12 data will have no interest in CCR5 RO.

  37. MD VIROLOGIST

    It is an idiosyncratic reaction but mostly from Coxsackieviruses

    (1)
  38. MD VIROLOGIST

    He does. That is why he thinks it is important, just hope it is part of CD12 which is the data FDA

    (1)
  39. MD VIROLOGIST

    We could here a statement that at x dose mortality is decreased but based on non-responders a

    (1)
  40. MD VIROLOGIST

    The drug is safe, this in clinical medicine is called crossing paradigms. What if 1000 mg is the

    (1)
  41. MD VIROLOGIST

    What if a dose three days later creates 100% occupancy and the patient lives, I think you are

    (1)
  42. mtruong34

    Your math assumes everyone in the CD12 trial was critical (e.g., requiring mechanical

    (3)
  43. MD VIROLOGIST

    Right but what if dosing becomes guided by roc studies on individual patients?

  44. smurph

    Is there a type of virus primarily responsible for that? seasonal flu even? friend got viral

  45. havasu78

    By "squishy", I mean that CD12 primary endpoint comes in with something on the order of 20-25%

    (3)
  46. sean007

    I saw a 48.6% reduction in mortality on another board earlier this a.m.

  47. sean007

    Evil..how about $10........an old adage...."insanity is doing the same thing over and over again

    (1)
  48. JLang

    It's actually super simple / easy, takes no time at all. Watch:

    (2)
  49. smurph

    MD VIRO', "if those with the highest occupancy survive it could lead to fast track." Other

  50. CDiddy

    Another great point

    (1)

Top 10 Most Recent News Articles

More News Articles

Top 5 Most Recently Viewed Articles

Angel Oak Mortgage Trust 2025-1 Receives Preliminary Ratings

Updated Category News Views 195

Angel Oak Mortgage Trust 2025-1 Ratings Overview KBRA has recently assigned preliminary ratings to various classes of mortgage-backed certificates associated with Angel Oak Mortgage Trust 2025-1 (AOMT 2025-1). This substantial transaction amounts to $342.0 million and comprises non-prime residential mortgage-backed securities (RMBS). It encompasses a pool of 631...

Continue Reading
Eagle Bancorp Montana Reports Positive Q3 Performance Growth

Updated Category News Views 177

Eagle Bancorp Montana's Strong Q3 Earnings Report Eagle Bancorp Montana, Inc. (NASDAQ: EBMT), the parent entity of Opportunity Bank of Montana, recently shared its financial results for the latest quarter. With net income reaching $2.7 million, or $0.34 per diluted share, this marks an upward trend from the previous quarter’s income of $1.7 million, equivalent to $0.22...

Continue Reading
Consumer Resilience Fuels Bank of America Amidst Slowing Trends

Updated Category News Views 310

Bank of America's Performance Overview Bank of America (NYSE: BAC) has reported a mixed performance in recent times, showing resilience in its earnings even as some sectors experience challenges. The bank's stock opened slightly higher, reflecting a cautious optimism in the market with shares trading around $46.50. For the quarter, Bank of America generated $26.6 billion...

Continue Reading
The Setai St. Maarten: A New Era in Caribbean Luxury

Updated Category News Views 136

The Setai St. Maarten: A Feast for the Senses In a stunning location along the coast, The Setai St. Maarten emerges as a jewel of luxury, introducing a captivating blend of elegance and tranquility to the Caribbean. This exciting new resort is poised to redefine the standards of Caribbean hospitality, creating unforgettable experiences for guests in a picturesque coastal...

Continue Reading
Cullinan Therapeutics Gears Up for Major Healthcare Events

Updated Category News Views 142

Cullinan Therapeutics Hosts Exciting Events at Major Conferences CAMBRIDGE, Mass. — Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a prominent biopharmaceutical firm, is set to engage the investment community with notable events at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting and the Jefferies 2025 Global Healthcare Conference. These gatherings...

Continue Reading